1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of prophylactic rituximab for the prevention of post transplant Epstein-Barr related lymphoproliferative disease (EBV-PTLD) following T cell depleted (TCD) unrelated or HLA-mismatched related hematopoietic cell transplantation (HCT): Efficacy, toxicity, and effect on subsequent B cell reconstitution
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Jakubowski, A. A.; Knowles, M. A.; Young, J. W.; Castro-Malaspina, H.; Prockop, S. E.; O'Reilly, R. J.; Papadopoulos, E. B.
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and immunogenicity of the 13-valent protein-conjugated pneumococcal vaccine(PCV13) following related and unrelated hematopoietic stem cell transplantation (HCT)
    Meeting Abstract

    Small, T. N.; Jakubowski, A. A.; Barker, J. N.; Kernan, N. A.; Prockop, S. E.; Iovino, C. S.; Lestrange, N.; Perales, M. A.; Castro-Malaspina, H.; Koehne, G.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Mutational analysis of therapy-related MDS/AML
    Meeting Abstract

    Shih, A. H.; Chung, S. S.; Dolezal, E. K.; Zhang, S. J.; Abdel-Wahab, O.; Park, C. Y.; Nimer, S. D.; Levine, R. L.; Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • A cytotoxic human monoclonal antibody recognizing cell surface WT1 peptide/HLA-A2 complexes
    Meeting Abstract

    Scheinberg, D. A.; Dao, T.; Yan, S. ; Zhou, L.; Korontsvit, T.; Zakhaleva, V.; Curcio, M.; Liu, C.
    Blood (2011)

    Fulltext@MSK | Save
  • MicroRNAs mediate resistance to tyrosine kinase inhibitors in Philadelphia-positive B-ALL by down-regulating key tumor suppressors
    Meeting Abstract

    Schatz, J. H.; Mavrakis, K.; Wolfe, A. L.; Wendel, H. G.
    Blood (2011)

    Fulltext@MSK | Save
  • Non-myeloablative allogeneic hematopoietic stem cell transplantation with low-dose total body irradiation and peri-transplant rituximab for B cell non-Hodgkin lymphoma: Favorable disease control in chemosensitive patients
    Meeting Abstract

    Sauter, C. S.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; Lechner, L.; Moskowitz, C. H.; Giralt, S.; Barker, J. N.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell (HSC) boosts from the original donor without conditioning for poor graft function (PGF) following allogeneic hematopoietic stem cell transplants (HSCT)
    Meeting Abstract

    Rosenzweig, M. A.; Kernan, N. A.; Small, T. N.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Boulad, F.; Giralt, S.; Young, J. W.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Dynamics of mutant alleles in patients with advanced essential thrombocythernia (ET) or polycythemia (PV) during pegylated interferon-alfa-2A (PEG-IFN-alpha-2A; pegasys) therapy
    Meeting Abstract

    Quintas-Cardama, A.; Abdel-Wahab, O.; Levine, R. L.; Manshouri, T.; Roupie, A. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Meeting Abstract

    Qazilbash, M.; Thall, P. F.; Liu, P.; Orlowski, R. Z.; Bashir, Q.; Shah, N.; Kebriaei, P.; Parmar, S.; Jones, R.; Hosing, C. M.; more...
    Blood (2011)

    Fulltext@MSK | Save